sapogenins and Parkinson-Disease

sapogenins has been researched along with Parkinson-Disease* in 1 studies

Other Studies

1 other study(ies) available for sapogenins and Parkinson-Disease

ArticleYear
Isolation of the sapogenin from defatted seeds of Camellia oleifera and its neuroprotective effects on dopaminergic neurons.
    Journal of agricultural and food chemistry, 2014, Jul-02, Volume: 62, Issue:26

    Sasanqua saponin is a major active compound in the defatted seeds of Camellia oleifera but is always discarded without effective utilization. The sapogenin from hydrolysis of sasanqua saponin was purified, and its amination derivative was investigated on its neuroprotective effects, which were evaluated by animal models of Parkinson disease in mice induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The results showed that the sapogenin and its derivative increased dopamine content in striatum and tyrosine hydroxylase (TH) positive cells in substantia nigra and relieved inflammation and behavioral disorder, but the effect on movement was reversed by dopamine receptor antagonist haloperidol and was not intervened by adenosine receptor antagonist CGS 15943. Molecular simulation showed the interaction between dopamine receptor and the sapogenin or its derivative. It is proven that the sapogenin can protect dopamine neurons through antineuroinflammation and activation of dopamine receptor rather than adenosine receptor, and its amination improves the effects. This research provides the prospective prodrugs for Parkinson disease and a new medicinal application of sasanqua saponin.

    Topics: Animals; Animals, Outbred Strains; Camellia; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Food-Processing Industry; Industrial Waste; Male; Mice; Neuroprotective Agents; Parkinson Disease; Random Allocation; Sapogenins; Seeds; Substantia Nigra

2014